The University at Buffalo (UB) Division of Behavioral Medicine is looking for participants who are overweight and over 18 years old. The goal of the study is to learn how the body uses sugar for energy, and the difference in eating sugar-free and sugar-sweetened Greek yogurt. Read More

Adults 18 years or older
Are overweight
Willing to eat Greek yogurt
Do not have Type-2 Diabetes

This study enrolls people with Myelodysplastic syndrome (MDS). The purpose of this study is to learn if the study drug, called Venetoclax, can help treat MDS. Read More

Adults ages 18+
Diagnosed with Myelodysplastic syndrome (MDS)
Please contact us for more information about eligibility.

This study enrolls people who will be having intestinal or gallbladder surgery. We want to see if a technology called ActivSight helps safely identify and visualize bile ducts, blood vessels, blood flow and the health of tissue during surgery without using fluorescent dye. Read More

Adults ages 18+
Will be having surgery to remove a part of your intestine or your gallbladder (aka laparoscopic or robot assisted intestinal anastomoses or laparoscopic cholecystectomy).

This study enrolls children who are having an intracranial or spinal fusion procedure. The purpose of this study is to learn about the DNA of children who develop an infection after surgery. The results of this study may help us learn how to better control infections in children after surgery in the future. Read More

Children ages 5-15.
Are having an intracranial or spinal fusion procedure.

This study enrolls healthy adults who will be getting a vaccine. The goal of this study is to learn about immune system cells called macrophages. Macrophages are important immune system cells that form when an infection is in the body. Read More

Adults ages 20-55.
Generally healthy.
Scheduled to receive a vaccine, like the COVID-19 or flu vaccine (for COVID-19 vaccine, study must be done before and after the first dose of the vaccine).

This study enrolls people who will be having a salivary gland biopsy at ECMC. The purpose of the study is to learn more about the tissue that makes saliva (salivary gland tissue). Read More

Adults ages 18+.
People who need minor salivary gland biopsy for suspected Sjogren's Syndrome.

This study enrolls adults with pancreatic cancer. The purpose of this study is to learn whether an experimental device, a Tumor Treating Fields (TTFields) device called NovoTTF-100L(P), will be safe and effective when used with gemcitabine and nab-paclitaxel (chemotherapy medications typically used to treat this cancer). Tumor Treating Fields (TTFields) are low intensity electric fields delivered with a small medical device. The fields are used on top of area on your body where your cancer is. The purpose is to disrupt the activity of dividing cancer cells. Read More

Adults ages 18+.
Diagnosed with adenocarcinoma of the pancreas (pancreatic cancer).
Interested and assigned by the investigator to have therapy with gemcitabine and nab-paclitaxel.

This study enrolls infants who are very premature. The purpose of the study is to learn which medications can help very premature babies breathe more easily. Read More

Children (infants) who have just been born.
Infants born between 22 and 28 weeks gestation OR 401-1000 grams birth weight.
Infant's physician has decided to treat them with surfactant.

This study enrolls people with TRK fusion cancer. The purpose of this study is to learn more about the effectiveness of the drug VITRAKVI (generic name: larotrectinib) for TRK fusion cancer that has spread from the place where it started to other places in the body. TRK fusion cancer is a term used to describe a variety of common and rare cancers that are caused by a change to the NTRK (Neurotrophic Tyrosine Kinase) gene called a fusion. VITRAKVI is an approved drug that blocks the action of the NTRK gene fusion. Read More

Adults 18+
Patients with TRK fusion cancer (locally advanced or metastatic solid tumor harboring an NTRK gene fusion).
Your physician has decided to treat you with larotrectinib.

This study enrolls adults with esophageal cancer. The purpose of this study is to compare the effects of different combinations of medications to treat this cancer. Atezolizumab and tiragolumab are experimental drugs, which means the U.S. Food and Drug Administration (FDA) has not approved them, alone or in combination, for the treatment of esophageal cancer. Read More

Adults ages 18+.
Diagnosed with esophageal cancer (squamous cell carcinoma of the esophagus) in stage II-IIVA.
The cancer is unresectable, which means you are unable to unwilling to have surgery.
You have received chemoradiotherapy and your disease did not worsen.